Iovance Biotherapeutics IOVA
Iovance Biotherapeutics, Inc. · Nasdaq · Biological Products, (No Diagnostic Substances)
$9.56-35.45%close on Oct. 29, 2026 · volume 58.5M · Yahoo Finance
Price, last 48 sessions
Our coverage
Nothing published yet.
Insider buying and selling
No open-market insider buying or selling in the Form 4s filed since July 24, 2026.
Recent SEC filings
All 17 →Other events · Financial statements and exhibits
AI summary, unreviewedIovance Biotherapeutics Reports Updated IOV-LUN-202 Non-Squamous mNSCLC Data: 24.6% ORR in 69 Patients, Biomarker-Enriched Subgroup at 59.1% ORR
Other events · Financial statements and exhibits
Other events · Financial statements and exhibits